Gubra AS (FRA:PI3) Total Receivables: €6.8 Mil (As of Dec. 2025)


FRA:PI3 Gubra AS FRA:PI3
73 GF Score
Price €44.08
GF Value €389.49
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Gubra AS Total Receivables?

Gubra AS FRA:PI3 +1.71% 73 Total Receivables is €6.8 Mil as of Dec. 2025. GuruFocus rates FRA:PI3 with a GF Score™ of 73/100 and a GF Value™ of €389.49 (Possible Value Trap). The stock has 3 warning signs investors should review.

Gubra AS's Total Receivables for the quarter that ended in Dec. 2025 was €6.8 Mil.

Gubra AS Total Receivables Historical Data

* Premium members only.

The historical data trend for Gubra AS's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gubra AS Total Receivables Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial 12.05 5.98 10.59 6.26 6.78

Gubra AS Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 10.59 5.03 6.26 7.11 6.78
FRA:PI3
73GF Score
Gubra AS FRA:PI3
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gubra AS Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of €6.8 Mil mean?
Gubra AS (FRA:PI3) has a Total Receivables of €6.8 Mil as of Dec. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Gubra AS and its competitors.
Is Gubra AS's Total Receivables too high?
Gubra AS's current Total Receivables is €6.8 Mil. Overall, Gubra AS has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gubra AS's Total Receivables compare to VRTX and REGN?
Gubra AS's Total Receivables of €6.8 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Gubra AS and its competitors. Gubra AS's current Total Receivables is €6.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gubra AS stock overvalued right now?
Based on GuruFocus' analysis, Gubra AS (FRA:PI3) is currently considered Possible Value Trap. The stock's GF Value™ is €389.49, compared to a current price of €44.08 — trading 88.7% below its estimated fair value. The current Total Receivables is €6.8 Mil. Gubra AS's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Gubra AS (FRA:PI3), the current Total Receivables is €6.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gubra AS (FRA:PI3) Overvalued in 2026?

Based on GuruFocus' analysis, Gubra AS stock appears to be undervalued. The current stock price of €44.08 is trading 88.7% below its estimated GF Value™ of €389.49. GuruFocus considers Gubra AS to be Possible Value Trap.

Key valuation signals for FRA:PI3:

  • Total Receivables: €6.8 Mil
  • GF Value™: €389.49 vs. price of €44.08 (88.7% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the FRA:PI3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gubra AS Business Description

Other Exchanges GUBRA:DenmarkPI3:Germany
Address Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
73GF Score

Get the complete analysis for FRA:PI3

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€44.08
Price
€389.49
GF Value